eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2019
vol. 44
 
Share:
Share:
abstract:
Clinical immunology

CD163 and CCR7 as markers for macrophage polarisation in lung cancer microenvironment

Iwona Kwiecień
1
,
Małgorzata Polubiec-Kownacka
2
,
Dariusz Dziedzic
2
,
Dominika Wołosz
3
,
Piotr Rzepecki
4
,
Joanna Domagała-Kulawik
5

1.
Department of Internal Medicine and Hematology, Laboratory of Flow Cytometry, Military Institute of Medicine, Warsaw, Poland
2.
Department of Surgery, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
3.
Department of Pathology, Medical University of Warsaw, Warsaw, Poland
4.
Department of Internal Medicine and Hematology, Military Institute of Medicine, Warsaw, Poland
5.
Department of Internal Medicine, Pulmonary Diseases, and Allergy, Medical University of Warsaw, Warsaw, Poland
(Centr Eur J Immunol 2019; 44 (4): 395-402)
Online publish date: 2020/01/20
View full text Get citation
 
PlumX metrics:
Introduction
M2 macrophages are predominant in the immune infiltrates of resected tumours, but little is known about macrophage phenotype in the local lung cancer environment, which may be evaluated by bronchoalveolar lavage fluid (BALF).

Aim of the study
To find differences between BALF from lung affected by cancer (clBALF) and hlBALF from the opposite, healthy lung, as a control, from the same patient, regarding their individual macrophage polarization and their correlation with IL-10 and TGF-.

Material and methods
Eighteen patients with confirmed lung cancer were investigated. Macrophage subtyping was performed by immunofluorescence with antibodies anti-CCR7 and CD163 (M1 and M2, respectively).

Results
We found five populations of macrophages: cells with a single reaction: only for CCR7+ or CD163+, a double reaction (CCR7+CD163+), cells with a stronger CD163 (CCR7lowCD163+), and cells with a stronger CCR7 (CCR7+CD163low). The main population in the clBALF was composed of cells with a phenotype similar to M2 (CCR7lowCD163+), while in the hlBALF the predominating phenotype was the one similar to M1 (CCR7+CD163low). The median proportion of TGF-1 concentration was higher in the clBALF and hlBALF supernatant than in the serum.

Conclusions
In this study we confirmed the usefulness of the immunofluorescence method with CCR7 and CD163 in the evaluation of BALF macrophage polarization in lung cancer.

keywords:

M1 macrophages, M2 macrophages, bronchoalveolar lavage fluid, CCR7, TGF-1, lung cancer

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.